Richard Straube

Chief Tech/Sci/R&D Officer at SOLIGENIX, INC.

Net worth: 320 $ as of 2024-03-30

72 year

100 connections

Health Technology

Consumer Services

Finance

Profile

Richard C.
Straube is currently the Chief Medical Officer & Senior Vice President at Soligenix, Inc. He previously held positions as Senior Director-Clinical Research & Immunology at Centocor, Inc. from 1988 to 1993, Director-Medical Affairs at T Cell Sciences, Inc. from 1993 to 1995, Director-Clinical Investigations at Ohmeda, Inc. from 1995 to 1997, Chief Scientific Officer, Executive VP-R&D at INO Therapeutics LLC from 1998 to 2007, Principal at Inomax LLC (Florida), and Chief Medical Officer at Stealth BioTherapeutics Corp.
from 2009 to 2014.
He also served as a Faculty Member at the University of California San Diego.
Dr. Straube holds a doctorate degree from The University of Chicago and a graduate degree from the London School of Hygiene & Tropical Medicine.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SOLIGENIX, INC. 0.01%	2024-03-07	534 ( 0.01% )	320 $	2024-03-30

Richard Straube active positions

Companies	Position	Start
SOLIGENIX, INC.	Chief Tech/Sci/R&D Officer	2014-01-05

All active positions of Richard Straube

Former positions of Richard Straube

Companies	Position	End
STEALTH BIOTHERAPEUTICS CORP	Chief Tech/Sci/R&D Officer	2014-01-05
Critical Biologics Corp. Critical Biologics Corp. Medical SpecialtiesHealth Technology Critical Biologics Corp. develops and commercializes diagnostics and therapeutics drugs. The firm focuses in the development of a theranostic platform to screen and treat both acute and chronic patients with low plasma gelsolin levels (hypogelsolinemia) at high risk of life-threatening complications. The company was founded by James W. Fordyce, Terence S. Russell, Shun Lee Po, and Thomas P. Stossel in 2006 and is headquartered in Cambridge, MA.	Chief Tech/Sci/R&D Officer	2008-12-31
INO Therapeutics LLC INO Therapeutics LLC Pharmaceuticals: MajorHealth Technology INO Therapeutics LLC engages in the development of pharmaceutical drugs. The company is headquartered in Hampton, NJ.	Chief Tech/Sci/R&D Officer	2006-12-31
Ohmeda, Inc.	Corporate Officer/Principal	1997-01-01
T Cell Sciences, Inc.	Chief Tech/Sci/R&D Officer	1994-12-31

See the detail of Richard Straube's experience

Training of Richard Straube

The University of Chicago	Doctorate Degree
London School of Hygiene & Tropical Medicine	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Richard Straube's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SOLIGENIX, INC.	Health Technology

Private companies	7
Centocor, Inc. Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA.	Health Technology
Critical Biologics Corp. Critical Biologics Corp. Medical SpecialtiesHealth Technology Critical Biologics Corp. develops and commercializes diagnostics and therapeutics drugs. The firm focuses in the development of a theranostic platform to screen and treat both acute and chronic patients with low plasma gelsolin levels (hypogelsolinemia) at high risk of life-threatening complications. The company was founded by James W. Fordyce, Terence S. Russell, Shun Lee Po, and Thomas P. Stossel in 2006 and is headquartered in Cambridge, MA.	Health Technology
T Cell Sciences, Inc.	Health Technology
INO Therapeutics LLC INO Therapeutics LLC Pharmaceuticals: MajorHealth Technology INO Therapeutics LLC engages in the development of pharmaceutical drugs. The company is headquartered in Hampton, NJ.	Health Technology
Inomax LLC (Florida) Inomax LLC (Florida) Investment ManagersFinance Inomax LLC is an American venture capital company.	Finance
Ohmeda, Inc.
Stealth BioTherapeutics Corp. Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. The company was founded on April 3, 2006 and is headquartered in Needham, MA.	Health Technology